流通市值:5.57亿 | 总市值:22.24亿 | ||
流通股本:1109.52万 | 总股本:4426.00万 |
报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 215,175,410.12 | 58,492,045.45 | 72,875,030.46 | 92,485,265.57 |
结算备付金 | 0 | - | - | - |
拆出资金 | 0 | - | - | - |
衍生金融资产 | 0 | 0 | - | - |
应收票据及应收账款 | 234,183,217.89 | 195,165,858.98 | 207,305,276.52 | 193,881,422.73 |
其中:应收票据 | 77,190,298.3 | 68,512,834.96 | 72,446,897.32 | 35,734,198.49 |
应收账款 | 156,992,919.59 | 126,653,024.02 | 134,858,379.2 | 158,147,224.24 |
应收款项融资 | 27,847,819.3 | 22,817,692.38 | 6,513,877.86 | 34,035,615.62 |
预付款项 | 2,665,138.82 | 1,874,438.82 | 1,907,511.77 | 1,223,082.33 |
应收保费 | 0 | - | - | - |
应收分保账款 | 0 | - | - | - |
应收分保合同准备金 | 0 | - | - | - |
其他应收款合计 | 9,142,558.07 | 7,562,473.08 | 8,802,329.92 | 10,035,937.18 |
其中:应收利息 | 0 | - | - | - |
应收股利 | 0 | - | - | - |
买入返售金融资产 | 0 | - | - | - |
存货 | 102,677,367.87 | 100,574,304.28 | 108,300,934.57 | 123,647,753.89 |
合同资产 | 0 | 0 | - | - |
一年内到期的非流动资产 | 0 | 0 | - | - |
其他流动资产 | 2,757,011.4 | 10,354,781.38 | 6,370,975.28 | 6,795,668.96 |
流动资产其他项目 | 0 | - | - | - |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 784,826,907.03 | 411,843,751.9 | 412,075,936.38 | 462,104,746.28 |
非流动资产: | ||||
发放委托贷款及垫款 | 0 | - | - | - |
债权投资 | 0 | - | - | - |
其他债权投资 | 0 | - | - | - |
长期应收款 | 0 | 0 | - | - |
长期股权投资 | 0 | 0 | - | - |
其他权益工具投资 | 0 | - | - | - |
其他非流动金融资产 | 0 | - | - | - |
投资性房地产 | 0 | - | - | - |
固定资产 | 103,396,627.91 | 104,868,737.45 | 83,451,845.77 | 86,119,799.22 |
在建工程 | 165,822,270.09 | 157,942,652.21 | 166,253,143.26 | 142,985,699.13 |
生产性生物资产 | 0 | - | - | - |
油气资产 | 0 | - | - | - |
使用权资产 | 28,662,313.73 | 29,799,361.25 | 30,774,471.95 | 31,503,729.38 |
无形资产 | 14,102,452.55 | 14,177,914.92 | 13,270,095.39 | 13,356,856.2 |
开发支出 | 0 | - | - | - |
商誉 | 0 | - | - | - |
长期待摊费用 | 8,238,223.06 | 8,468,993.9 | 8,347,429.78 | 8,175,719.18 |
递延所得税资产 | 2,493,654.98 | 2,477,124.34 | 2,737,085.71 | 3,292,534.47 |
其他非流动资产 | 2,298,049.65 | 4,427,256.65 | 3,783,903.73 | 4,280,041.4 |
非流动资产其他项目 | 0 | - | - | - |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 325,013,591.97 | 322,162,040.72 | 308,617,975.59 | 289,714,378.98 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 1,109,840,499 | 734,005,792.62 | 720,693,911.97 | 751,819,125.26 |
流动负债: | ||||
短期借款 | 0 | 16,015,644.44 | 16,012,800 | 33,181,610.41 |
向中央银行借款 | 0 | - | - | - |
吸收存款及同业存放 | 0 | - | - | - |
拆入资金 | 0 | - | - | - |
交易性金融负债 | 0 | 0 | - | 1,520,100 |
衍生金融负债 | 0 | - | - | - |
应付票据及应付账款 | 138,002,151.14 | 142,765,668.84 | 166,480,800.49 | 197,287,172.76 |
其中:应付票据 | 25,108,162.48 | 44,946,628.16 | 45,479,909.58 | 55,228,575.96 |
应付账款 | 112,893,988.66 | 97,819,040.68 | 121,000,890.91 | 142,058,596.8 |
预收款项 | - | 0 | - | - |
合同负债 | 99,059.17 | 118,249.44 | 166,828.84 | 66,044.99 |
卖出回购金融资产款 | 0 | 0 | - | - |
应付手续费及佣金 | 0 | - | - | - |
应付职工薪酬 | 6,675,312.44 | 5,846,015.65 | 5,465,211.36 | 5,900,103.01 |
应交税费 | 1,474,839.75 | 1,542,362.76 | 2,224,406.54 | 4,989,876.03 |
其他应付款合计 | 3,637,670.58 | 6,453,783.95 | 3,663,591.4 | 4,035,073.65 |
其中:应付利息 | 0 | - | - | - |
应付股利 | 0 | - | - | - |
应付分保账款 | 0 | - | - | - |
保险合同准备金 | 0 | - | - | - |
代理买卖证券款 | 0 | - | - | - |
代理承销证券款 | 0 | - | - | - |
一年内到期的非流动负债 | 29,325,626.57 | 12,708,323.58 | 8,990,581.36 | 6,434,903.67 |
其他流动负债 | 47,459,203.08 | 7,263,935.95 | 21,687.74 | 8,585.85 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 226,673,862.73 | 192,713,984.61 | 203,025,907.73 | 253,423,470.37 |
非流动负债: | ||||
长期借款 | 83,273,938.84 | 87,583,359.5 | 78,913,846 | 72,480,776.5 |
应付债券 | 0 | 0 | - | - |
优先股 | 0 | 0 | - | - |
永续债 | 0 | - | - | - |
租赁负债 | 24,432,442.43 | 29,400,752.22 | 30,284,604.22 | 31,030,909.24 |
长期应付款 | 0 | 0 | - | - |
长期应付职工薪酬 | 0 | 0 | - | - |
预计负债 | 0 | 0 | - | - |
递延收益 | 3,545,000.09 | 2,209,998.3 | 1,741,969.7 | 1,820,218.61 |
递延所得税负债 | 0 | - | - | - |
其他非流动负债 | 0 | 0 | - | - |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 111,251,381.36 | 119,194,110.02 | 110,940,419.92 | 105,331,904.35 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 337,925,244.09 | 311,908,094.63 | 313,966,327.65 | 358,755,374.72 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 44,260,000 | 33,164,851 | 33,164,851 | 33,164,851 |
其他权益工具 | 0 | 0 | - | - |
优先股 | 0 | 0 | - | - |
永续债 | 0 | - | - | - |
资本公积 | 432,494,174.63 | 100,362,106.15 | 100,117,188.8 | 99,872,271.45 |
减:库存股 | 0 | - | - | - |
其他综合收益 | -145,914.42 | -29,885.92 | -138,827.84 | -191,357.37 |
专项储备 | 0 | - | - | - |
盈余公积 | 18,820,576.73 | 18,820,576.73 | 18,820,576.73 | 18,820,576.73 |
一般风险准备 | 0 | 0 | - | - |
未分配利润 | 276,486,417.97 | 269,780,050.03 | 254,763,795.63 | 241,397,408.73 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 771,915,254.91 | 422,097,697.99 | 406,727,584.32 | 393,063,750.54 |
少数股东权益 | 0 | - | - | - |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 771,915,254.91 | 422,097,697.99 | 406,727,584.32 | 393,063,750.54 |
负债和股东权益合计 | 1,109,840,499 | 734,005,792.62 | 720,693,911.97 | 751,819,125.26 |
公告日期 | 2024-04-26 | 2024-04-26 | 2024-01-11 | 2023-09-28 |
审计意见(境内) | 标准无保留意见 | 标准无保留意见 |